Unna Boot Market Report and Forecast 2025-2034

The global unna boot market size was valued at USD 122.70 Million in 2024, driven by the rising prevalence of venous leg ulcers across the globe. The market is expected to grow at a CAGR of 5.07% during the forecast period of 2025-2034, with the values likely to rise from USD 128.9 Million in 2025 to USD 201.20 Million by 2034.

Global Unna Boot Market Overview

Unna boot is a gauze bandage impregnated with glycerine, zinc oxide, and calamine lotion. As an inelastic compression therapy, it works by increasing compression and providing venous support, aiding the healing of the ulcer. Unna boots find their application across several medical domains including wound care. It provides improvement in comfort, granulation tissue formation, and cost savings when compared to other compression therapies.

Venous leg ulcers are the most commonly occurring leg ulcers, accounting for 70% of all cases. Unna boots are widely used as a compression therapy in reducing venous hypertension and preventing edema. Consequently, the unna boot market growth is likely to increase in upcoming years. It is also used in combination with other treatments such as topical corticosteroids to treat various dermatological conditions including eczema and other inflammatory skin diseases. Furthermore, a significant segment of the geriatric population is likely to adopt unna boot in the coming years which will also increase the market demand.

The market is further driven by a surge in accidents and sports related injuries. According to the data published in Injury Prevention (BMJ Journals) it was revealed that around 5.40 sports or trauma related injuries occurred in every 100,000 participants. Conducted in England and Wales population, the incidence rate was found to be 6.44 per 100,000 in men and 3.34 per 100,000 in women. Unna boots are helpful in protecting the wound site and keep it moisture and itch-free as well. Consequently, the rise in prevalence of injuries is anticipated to boost the unna boot market share in the forecast period.

Rise in Venous Leg Ulcer Cases to Drive Market Growth

Chronic venous insufficiency and venous hypertension are the leading causes of venous leg ulcers (VLU), representing a prominent clinical challenge for both developed and developing economies. It affects the lower limbs and accounts for 60-80% of all leg ulceration. The prevalence rate is reported to be around 1.08%. In addition, it was revealed that the prevalence and incidence of VLUs increase with age, representing a significant social and economic burden, estimated to cost USD 3 billion in the United States annually. As the number of patients with VLUs continues to rise, the unna boot market demand is poised to grow to provide compression to the affected leg.

Cost-Effective Alternative for Treating Venous Ulcers

Unna boot dressing represents a low-cost alternative to wound healing, especially in the management of venous leg ulcers (VLU). The high prevalence and chronicity of venous ulcers necessitate the demand for effective and cost-saving treatment solutions. In March 2023, a study published in Revista Latino-Americana de Enfermagem (RLAE) analyzed the cost-effectiveness of compressive therapies including unna boot therapy to heal venous ulcers. According to the quantitative study, unna boot stood as the second most cost-effective alternative in the healing of venous ulcers. In Brazil, unna boot dressing was the most commonly used method as an inelastic therapy. Thus, the affordability of unna boot is attributed to its dominance in the compressive therapies market.

Global Unna Boot Market Segmentation

Unna Boot Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Application

• Venous Leg Ulcers
• Lymphedema
• Eczema

Market Breakup by Raw Material

• Zinc Oxide
• Zinc
• Calamine

Market Breakup by Distribution Channel

• Offline Retail
• Online Retail

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Unna Boot Market Regional Analysis

North America accounts for a significant share of the unna boot market due to the rising prevalence of eczema, venous leg ulcers, and lymphedema in the region. The latest data released by the National Eczema Association shows that 10.1% of the population in the United States which is equivalent to 31.6 million individuals are affected by some type of eczema. Moreover, it is estimated that 1 in 10 people will develop the condition in their lifetime, which is expected to elevate the unna boot market size in the forecast period. In addition, the market growth can be attributed to the high awareness among patients, the dedication of caregivers, and the advanced healthcare infrastructure.

Europe holds a substantial portion of the market share which can be attributed to the presence of major research institutes and leading healthcare companies in the region. Asia Pacific is also predicted to witness notable growth in the unna boot market in the coming years, owing to the large geriatric population base and the increased healthcare expenditure to improve patient outcomes.

Global Unna Boot Market: Competitor Landscape

One of the major market trends is significant investments made by the key market players to expand their manufacturing and distribution capacities. In December 2023, a leading United States-based healthcare company known for its innovative Unna boot compression bandages, Medline Industries Inc., announced an additional investment worth USD 300 million to support its Healthcare Resilience Initiative that already boasted a USD 2 billion investment. The funding will help meet the growing supply chain needs and will ensure the delivery of superior clinical solutions and medical supplies.

The key features of the unna boot market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Medline Industries, Inc.
• Cardinal Health
• American Medicals
• Essity Health & Medical
• Convatec Inc.
• GF Health Products, Inc.
• Dynarex Corporation
• 3M
• Baxter
• Pfizer Inc.
• B. Braun SE
• Paul Hartmann AG
• Molnlycke Health Care AB
• Beiersdorf
• Coloplast Corp

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

This product will be delivered within 3-5 business days.